This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: University of Vermont. Active years: 2019-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Winooski, VT (US) (2019)
- Colchester, VT (US) (2022)
Company Filing History:
Years Active: 2019-2022
Title: Rajiv Satish Jumani: Innovator in Pharmaceutical Treatments
Introduction
Rajiv Satish Jumani is a notable inventor based in Colchester, Vermont, who has made significant contributions to the field of pharmaceutical treatments. With a focus on innovative methods for addressing health challenges, Jumani has been awarded 2 patents for his groundbreaking work.
Latest Patents
Jumani's latest patents include methods for treating cryptosporidiosis using triazolopyridazines. These patents detail methods for treating or providing prophylaxis for infections using compositions that comprise specific structures disclosed within the patents. Additionally, the patents provide pharmaceutical compositions and kits designed to alleviate symptoms, treat, or prevent the occurrence of infections. The kits include one or more compounds with the disclosed structures, often in oral compositions, along with instructions for use and storage.
Career Highlights
Rajiv Satish Jumani is affiliated with the University of Vermont, where he continues to advance his research and innovation in the pharmaceutical field. His work is characterized by a commitment to developing effective treatments for infectious diseases.
Collaborations
Throughout his career, Jumani has collaborated with esteemed colleagues, including Christopher D. Huston and Kovi Bessoff. These collaborations have further enriched his research and contributed to the development of his patented methods.
Conclusion
Rajiv Satish Jumani stands out as an influential inventor in the realm of pharmaceutical innovations, particularly in the treatment of cryptosporidiosis. His contributions continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
